Thyroid Hormone and the Cardiovascular System

Medical Clinics of North America

Volumn 96, Issue 2, 2012, Pages 257-268

  Danzi, Sara ^a   Klein, Irwin ^b  

^a QUEENSBOROUGH COMMUNITY COLLEGE   (United States)

^b Private Practice   (United States)

Author keywords

Cardiovascular system; Heart; Hemodynamics; Thyroid hormone

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELL NUCLEUS RECEPTOR; LIOTHYRONINE; PROPRANOLOL; RADIOACTIVE IODINE; THIAMAZOLE; THYROID HORMONE;

CELL FUNCTION; CELL METABOLISM; CHOLESTEROL METABOLISM; DRUG SAFETY; HEART DISEASE; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NEGATIVE FEEDBACK; NONHUMAN; PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE METABOLISM; THYROTOXICOSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSELS; CALCIUM-TRANSPORTING ATPASES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; HEART; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THYROID HORMONES; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE; VENTRICULAR MYOSINS;

EID: 84858759988     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.01.006     Document Type: Review

References (60)

1. Klein I., Danzi S. Thyroid disease and the heart. Circulation 2007, 116:1725-1735.
2. Dillmann W.H. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 2010, 15:125-130.
3. Klein I. Endocrine disorders and cardiovascular disease. Braunwald's heart disease 2011, 1829-1843. WB Saunders and Company, St Louis (MO), Chapter 86. 9th edition. R.O. Bonow, D.L. Mann, D.P. Zipes (Eds.).
4. Demers L.M., Spencer C.A. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3.
5. Koenig R.J. Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid 2005, 15:835.
6. Visser W.E., Wong W.S., van Mullem A.A., et al. Study of the transport of thyroid hormone by transporters of the SLC10 family. Mol Cell Endocrinol 2010, 315(1-2):138-145.
7. Everts M.E., Verhoeven F.A., Bezstarosti K., et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology 1996, 137:4235-4242.
8. Pingitore A., Galli E., Barison A., et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008, 93:1351-1358.
9. Visser W.E., Friesema E.C., Visser T.J. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 2011, 25:1-14.
10. Dumitrescu A.M., Liao X.H., Best T.B., et al. A novel syndrome combining thyroid and neurological abnormalities associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004, 74:168-175.
11. Friesema E.C., Jansen J., Jachtenberg J.W., et al. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 2008, 22:1357-1369.
12. Dumitrescu A.M., Liao X.H., Weiss R.E., et al. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (Mct) 8-deficient mice. Endocrinology 2009, 150:4450-4458.
13. Lazar M. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 1993, 14:184-193.
14. Hodin R., Lazar M., Chin W. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J Clin Invest 1990, 85:101-105.
15. Xu L., Glass C.K., Rosenfeld M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999, 9(2):140-147.
16. Balkman C., Ojamaa K., Klein I. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 1992, 130:2001-2006.
17. Sylven C., Jansson E., Sotonyi P., et al. Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Sci 1996, 599(22):1917-1922.
18. Ojamaa K., Samarel A., Kupfer J., et al. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol 1992, 263:E534-E540.
19. Danzi S., Klein S., Klein I. Differential regulation of myosin heavy chain genes α and β in the rat atria and ventricles: role of antisense RNA. Thyroid 2008, 18(7):761-768.
20. 2+ release involved in positive inotropic effect mediated by CGRP in ventricular myocytes. Am J Physiol 1999, 276:R259-R264.
21. Koss K.L., Kranias E.G. Phospholamban, a prominent regulator of myocardial contractility. Circ Res 1996, 79:1059-1063.
22. 2+ transient of failing human ventricular myocytes. Circ Res 1999, 84:435-444.
23. Kiss E., Brittsan A.G., Edes I., et al. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ Res 1998, 83:608-613.
24. Bluhm W.F., Meyer M., Sayen M.R., et al. Overexpression of sarcoplasmic reticulum Ca2+ ATPase improves cardiac contractile function in hypothyroid mice. Cardiovasc Res 1999, 43:382-388.
25. Danzi S., Ojamaa K., Klein I. Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am J Physiol Heart Circ Physiol 2003, 284:H2255-H2262.
26. 3 syndrome. Am J Physiol 1997, 273:E951-E956.
27. Danzi S., Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep 2003, 5:513-520.
28. Bengel F.M., Lehnert J., Ibrahim T., et al. Cardiac oxidative metabolism, function, and metabolic performance in mild hyperthyroidism: a noninvasive study using positron emission tomography and magnetic resonance imaging. Thyroid 2003, 13:471-477.
29. Biondi B., Palmieri E.A., Lombardi G., et al. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 2002, 87:968-974.
30. Klein I., Hong C. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 1986, 77:1694-1698.
31. Ismail H.M. Reversible pulmonary hypertension and isolated right-sided heart failure associated with hyperthyroidism. J Gen Intern Med 2007, 22:148-150.
32. Di Giovambattista R. Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure. Cardiovasc Ultrasound 2008, 6:29.
33. Delit C., Silver S., Yohalem S.B., et al. Thyrocardiac disease and its management with radioactive iodine I-131. JAMA 1961, 176:262-267.
34. Klein I, Danzi S. The cardiovascular system in thyrotoxicosis. In: Braverman L, Utiger R, editors. Werner & Ingbar's the thyroid: a fundamental and clinical text. 10th edition. Philadelphia: Lippincott Williams & Wilkins; in press. Chapter 31.
35. Shimizu T., Koide S., Noh J.Y., et al. Hyperthyroidism and the management of atrial fibrillation. Thyroid 2002, 12:489-493.
36. Dahl P., Danzi S., Klein I. Thyrotoxic cardiac disease. Curr Heart Fail Rep 2008, 5(3):170-176.
37. Olsen B., Klein I., Benner R., et al. Hyperthyroid myopathy and the response to treatment. Thyroid 1991, 1:137-141.
38. Kahaly G., Kampmann C., Mohr-Kahaly S. Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 2002, 12:473.
39. Mintz G., Pizzarello R., Klein I. Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab 1991, 73:146-150.
40. Bahn R.S., Burch H.B., Cooper D.S., et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011, 17(3):456-520.
41. Klein I., Becker D., Levey G.S. Treatment of hyperthyroid disease. Ann Intern Med 1994, 121:281-288.
42. Cappola A.R., Ladenson P.W. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003, 88:2438-2444.
43. Biondi B., Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004, 24:1-14.
44. Rodondi N., den Elzen W.P., Bauer D.C., et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010, 304:1365-1374. Thyroid Studies Collaboration.
45. Klein I., Ojamaa K. Mechanisms of disease: thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344:501-509.
46. Sawin C.T., Geller A., Wolf P.A., et al. Low serum thyrotropin levels as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 33:1249.
47. Nakazawa H., Lythall D.A., Noh J., et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. Eur Heart J 2000, 21:327.
48. Ventrella S., Klein I. Beta-adrenergic receptor blocking drugs in the management of hyperthyroidism. Endocrinologist 1994, 4:391-399.
49. Petersen P., Hansen J.M. Stroke in thyrotoxicosis with atrial fibrillation. Stroke 1988, 19:15.
50. Ladenson P.W., Kristensen J.D., Ridgway E.C., et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med 2010, 362:906-916.
51. Martino E., Bartalena L., Bogassi F., et al. The effects of amiodarone on the thyroid. Endocr Rev 2001, 22:240.
52. Cohen-Lehman J., Dahl P., Danzi S., et al. Effects of amiodarone on thyroid function. Nat Rev Endocrinol 2010, 6:34-41.
53. Kathofer S., Thomas D., Karle C.A. The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovasc Drug Rev 2005, 23:217.
54. Bogazzi F., Bartalena L., Cosci C., et al. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 2003, 88:1999.
55. Williams M., Lo Gerfo P. Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. Thyroid 2002, 12:523.
56. DeGroot L.J. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999, 84:151-164.
57. Ascheim D.D., Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 2002, 12:511.
58. Iervasi G., Pingitore A., Landi P., et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003, 107:708-713.
59. Klein I, Danzi S. The cardiovascular system in hypothyroidism. In: Braverman L, Utiger R, editors. Werner & Ingbar's the thyroid: a fundamental and clinical text. 10th edition. Philadelphia: Lippincott Williams & Wilkins; in press. Chapter 53.
60. Danzi S., Klein I. Post-transcriptional regulation of myosin heavy chain expression in the heart by triiodothyronine. Am J Physiol Heart Circ Physiol 2005, 288:H455-H460.